National Institutes of Health

The National Institutes of Health awarded a nearly $4 million grant meant to fund research on psilocybin, the active ingredient in “magic mushrooms,” to researchers at Johns Hopkins University. The event marks the first grant awarded by the federal agency to any research relating to a...

Emergent BioSolutions Inc (NYSE: EBS) has announced the initiation of a Phase 3 trial that will evaluate its investigational SARS-CoV-2 Immune Globulin Intravenous (Human) (COVID-HIG) plasma-derived therapy. Related: Emergent BioSolutions' Plasma-Based Therapy Candidate...

Trevena Inc's (NASDAQ: TRVN) TRV027 has been selected for an NIH ACTIV trial in COVID-19 patients that will be dosed in ~300 COVID-19 patients. TRV027 combats disruption within the renin-angiotensin-aldosterone system (RAAS) by specifically binding to and rebalancing AT1...

The National Institutes of Health (NIH) has begun a mid-stage study to determine the risk of allergic reactions shortly after receiving COVID-19 vaccines made by Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX)....

The National Institutes Of Health said Tuesday that after reviewing available evidence from published and unpublished data on convalescent plasma therapy for COVID-19, it had concluded there is no case for recommending or advising against such a treatment. What Happened: The COVID-19 Treatment...

The National Institutes Of Health is set to investigate a Gilead Sciences, Inc (NASDAQ: GILD) compound, similar to remdesivir, which could be effective against COVID-19, Stat reported Monday. What Happened: The Francis Collins-led agency concluded that the compound known as GS-441524...

Pain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma. What Happened Pain Therapeutics has been awarded a research grant of...

Neither Republicans nor Democrats are eager to cut the National Institutes of Health funding by the president’s suggested $5.8 billion, but with the proposal still on the table, the sum is not yet safe. And as 18 percent of the current $31.7 billion budget hangs in the balance, more Americans...

According to a report by Reuters, researchers in the U.S. began the first clinical trial of a Zika vaccine, but there is one major issue. The Obama Administration said on Wednesday that funds allocated toward combating the Zika virus will run out soon due to congressional inaction. Unfortunately,...

Shares of Medivation Inc (NASDAQ: MDVN) were trading lower by more than 6 percent heading into Tuesday's market open as the company's drug pricing have come under scrutiny by the U.S. Congress. According to ABC News, a group of U.S. lawmakers initiated a campaign to potentially lower the price of...

Investors and traders were in clear selling mode today ahead of a very busy week of earnings. The Dow suffered a triple digit point loss while the S&P 500 and Nasdaq suffered losses of more than one percent. There were no key economic data releases today. Related: Earnings Expectations For...